Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
LEO Pharma |
---|---|
Information provided by: | LEO Pharma |
ClinicalTrials.gov Identifier: | NCT00404196 |
To compare the efficacy and safety of two different dose combinations of LEO19123 cream (calcipotriol and LEO80122) with LEO19123 cream vehicle for 3 weeks in the treatment of patients with hand eczema.
Condition | Intervention | Phase |
---|---|---|
Hand Eczema |
Drug: Calcipotriol and LEO80122 (LEO19123 cream) |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | LEO19123 Cream in the Treatment of Hand Eczema |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | LEO19123-C22 |
Study First Received: | November 27, 2006 |
Last Updated: | August 2, 2007 |
ClinicalTrials.gov Identifier: | NCT00404196 History of Changes |
Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Calcipotriene Skin Diseases Skin Diseases, Eczematous Eczema Dermatitis |
Calcipotriene Skin Diseases Therapeutic Uses Skin Diseases, Eczematous |
Eczema Dermatologic Agents Pharmacologic Actions Dermatitis |